Getinge (PINK:GETI B) said it plans to offer roughly $189 million to acquire Pulsion Medical Systems, a German cardiac monitoring company.
Getinge
ArjoHuntleigh taps Covidien executive | Personnel Moves
Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.
Getinge posts H1 sales growth, profits slide 33%
Getinge (PINK:GETI B) reported sales growth for the 1st half of the year, but said profits were down by nearly a third.
The Swedish healthcare firm, which owns medical device company Maquet, posted profits of roughly $95.6 million, or 40¢ per share, on sales of $1.74 billion for the 6 months ended June 30.
Maquet acquires LAAx and its TigerPaw II heart implant
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular said it bought LAAx Inc and its TigerPaw II heart implant for an undisclosed amount.
Maquet’s Class I ventilator battery recall affects 90k units
A Class I recall, reserved for serious patient harm, was issued over battery units produced by Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular.
Maquet lands FDA nod for Air-Band catheter device
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular racked up a win for another of its devices designed to close artery incisions for catheters after the FDA cleared its Air-Band radial compression device for the U.S. market.
The device is designed to help seal the radial artery after a catheterization procedure, in which the catheter is threaded into the heart via a radial artery incision in the wrist.
Layoffs: Zimmer Spine, Getinge shutter plants in Texas
KCI carves out TSS bedmaking biz to Getinge for $275M | Wall Street Beat
Kinetic Concepts said it’s closed the sale of its Therapeutic Support Systems business to Swedish medical device company Getinge (PINK:GETI B) for $275 million.
M&A: KCI sells Therapeutic Support Systems business to Getinge for $275 million
Kinetic Concepts is selling its Therapeutic Support Systems business to Getinge AB for $275 million, as the company looks to focus on its core wound care business.
Boston Scientific’s Innova peripheral stent débuts in Europe | Regulatory Roundup
Boston Scientific (NYSE:BSX) said it plans to get its Innova stent for peripheral artery disease on the market in the European Union "immediately" now that it’s won CE Mark approval there.
Stryker ex-CEO MacMillan resigns from Texas Instruments board | Personnel Moves
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.